Series date:
01/01/2026 - 7:00am to 12/31/2026 - 8:00am
COURSE DIRECTORS
Now Bahar Alam, M.D.
Timothy Burns, M.D.
Now Bahar Alam, M.D.
Timothy Burns, M.D.
DESCRIPTION
Tumor board instituted a monthly journal review in 2023. Providers from all participating specialties (surgery, medical oncology, radiation oncology, pathology, radiology) as well as additional participants (clinical genomics, pharmacy) have presented published journals within their respective fields and review article(s) with the tumor board once per month. This is a shared responsibility across all specialties and improves multidisciplinary education for all tumor board participants.
In-Person and Live-Streamed; 1x a Month on Friday from 7:00-8:00 a.m.
Tumor board instituted a monthly journal review in 2023. Providers from all participating specialties (surgery, medical oncology, radiation oncology, pathology, radiology) as well as additional participants (clinical genomics, pharmacy) have presented published journals within their respective fields and review article(s) with the tumor board once per month. This is a shared responsibility across all specialties and improves multidisciplinary education for all tumor board participants.
In-Person and Live-Streamed; 1x a Month on Friday from 7:00-8:00 a.m.
TARGET AUDIENCE
Allied Health Professionals, Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Resident Fellows, and Students.
Allied Health Professionals, Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Resident Fellows, and Students.
LEARNING OBJECTIVES
upon conclusion of this activity, participants should be able to:
upon conclusion of this activity, participants should be able to:
- Review new information affecting cancer management
- Determine multi-modality management of tumor types
- Describe diagnosis of breast cancer patients
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery - American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
None
All relevant financial relationships listed for these individuals have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Relevant financial relationship(s) with ineligible companies:
None
All relevant financial relationships listed for these individuals have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Now Bahar Alam, M.D.
Timothy Burns, M.D.
Timothy Burns, M.D.
Kaye Sturz, C.N.P., D.N.P., A.P.N.P., M.S.
Amy Hobbs (Coordinator)
Amy Hobbs (Coordinator)
Rebecca McInnis (Coordinator)
References to off-label and/or investigational usage(s) of pharmaceuticals or instruments in their presentation and/or content:
None
Where did the idea for the course originate?:
Minnesota

Facebook
X
LinkedIn
Forward